Meta-analysis of individual patient data from randomized trials: A review of methods used in practice

Clinical Trials

Volumn 2, Issue 3, 2005, Pages 209-217

  Simmonds, Mark C ^a   Higgins, Julian P T ^a   Stewart, Lesley A ^b   Tierney, Jayne F ^b   Clarke, Mike J ^c   Thompson, Simon G ^a  

^a MRC BIOSTATISTICS UNIT   (United Kingdom)

^b MRC CLINICAL TRIALS UNIT   (United Kingdom)

^c UK COCHRANE CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COVARIATE TREATMENT INTERACTION; DATA ANALYSIS; HEALTH CARE; HUMAN; INDIVIDUAL PATIENT DATA; META ANALYSIS; METHODOLOGY; PATIENT INFORMATION; PRIORITY JOURNAL; RANDOM EFFECTS METHOD; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; TIME TO EVENT OUTCOME; TREATMENT OUTCOME;

DATA INTERPRETATION, STATISTICAL; DISEASE-FREE SURVIVAL; HUMANS; META-ANALYSIS; MORTALITY; RANDOMIZED CONTROLLED TRIALS; TIME FACTORS; TREATMENT OUTCOME;

EID: 21344439360     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1191/1740774505cn087oa     Document Type: Review

References (73)

1. Egger M, Davey Smith G, Phillips AN. Meta-analysis; principles and procedures. BMJ 1997; 315: 1533-37.
2. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986; 7: 177-88.
3. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of clinical trials. Stats Med 1991; 10: 1665-77.
4. Stewart LA, Tierney JF. To IPD or not to IPD? Eval Health Prof 2002; 25: 76-97.
5. Schmid CH, Stark PC, Berlin JA et al. Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. J Clin Epidemiol 2004; 57: 683-97.
6. Lambert PC, Sutton AJ, Abrams KR et al. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J Clin Epidemiol 2002; 55: 86-94.
7. Berlin J, Santanna J, Schmid C et al. Anti-Lymphocyte Antibody Induction Therapy Study Group. Individual patient versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med 2002; 21: 371-87.
8. Stewart LA, Clarke MJ. Practical methodology of meta-analyses (overviews) using updated individual patient data. Stats Med 1995; 14: 2057-79.
9. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Nat Cancer Inst 1959; 22: 719-48.
10. Yusuf S, Peto R, Lewis J et al. Beta blockade during and after myocardial infarction: an overview of the randomised trials. Prog Cardio Dis 1985; 27: 335-71.
11. Turner RM, Omar RZ, Yang M et al. A multilevel model framework for meta-analysis of clinical trials with binary outcomes. Stats Med 2000; 19: 3417-32.
12. Higgins JPT, Whitehead A, Turner RM et al. Meta-analysis of continuous outcome data from individual patients. Stats Med 2001; 20: 2219-41.
13. Whitehead A, Omar RZ, Higgins JPT et al. Meta-analysis of ordinal outcomes using individual patient data. Stats Med 2001; 20: 2243-60.
14. Higgins JPT, Green S ed. Cochrane handbook for systematic review of interventions. In The Cochrane Library, Issue 2. Chichester: John Wiley and Sons, 2005.
15. Jafar TH, Schmid CH, Landa M et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Annals of Internal Medicine 2003; 139: 244-52.
16. ACE Inhibitors in Diabetic Neuropathy Trialist Goup. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin- converting enzyme inhibitors? Ann Intern Med 2001; 134: 370-79.
17. Adachi JD, Roux C, Pitt PI et al. A pooled data analysis of the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss. J Rheumatology 2000; 27: 2424-31.
18. Arnott SJ, Duncan W, Gignoux M et al. Preoperative radiotherapy for esophageal carcinoma (Cochrane review). In The Cochrane Library, Issue 4. Oxford: Update Software, 2001.
19. Artemether-Quinine Meta-analysis Study Group. Meta-analysis using individual patient data of trials comparing artemeter with quinine in the treatment of severe falciparum malaria. Trans Roy Soc Trop Med Hyg 2001; 95: 637-50.
20. Barnett PG, Rodgers JH, Bloch DA. A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence. Addiction 2001; 96: 683-90.
21. Chen Z, Sandercock P, HongChao P et al. Indications for early aspirin use in acute ischemic stroke. Stroke 2000; 31: 1240-49.
22. Chronic Myeloid Leukaemia Trialists' Collaborative Group. Hydroxyurea versus busulphan for chronic myeloid leukaemia: an individual patient data meta-analysis of three randomized trials. Br J Heamatology 2000; 110: 573-76.
23. CLL Trialists' Collaborative Group. Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. J Nat Cancer Inst 1999; 91: 861-68.
24. Colorectal Cancer Collaborative Group. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. BMJ 2000; 321: 531-35.
25. Connoly SJ, Hallstrom AP, Cappato R et al. Meta-analysis of the implantive cardioverter defibrilator secondary prevention trials. Eur Heart J 2000; 21: 2071-78.
26. Derbyshire J, Foulkes M, Peto R et al. Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults carcinoma (Cochrane review). In The Cochrane Library, Issue 4. Oxford: Update Software, 2001.
27. Darbyshire J, Foulkes M, Peto R et al. Zidovudine (AZT) versus AZT plus didanosine (DDI) versus AZT plus zalcitabine (DDC) in HIV infected adults carcinoma (Cochrane review). In The Cochrane Library, Issue 4. Oxford: Update Software, 2001.
28. Davis JM, Chen MS. The effects of olanzapine on the 5 dimensions of schizophrenia derived by factor analysis: combined results of the North American and international trials. J Clin Psychiatry 2001; 62: 757-71.
29. Daya S, Gunby J, Porter F et al. Critical analysis of intravenous immunoglobulin therapy for recurrent miscarriage. Human Reproduction Update 1999; 5: 475-82.
30. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer carcinoma (Cochrane review). In The Cochrane Library, Issue 4. Oxford: Update Software, 2001.
31. Early Breast Cancer Trialists' Collaborative Group. Multi-agent chemotherapy for early breat cancer carcinoma (Cochrane review). In The Cochrane Library, Issue 4. Oxford: Update Software, 2001.
32. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000; 355: 1757-70.
33. Entsuah RA, Huang H, Thase ME. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo. J Clin Psychiatry 2001; 62: 869-77.
34. Ferrari MD, Roon KI, Lipton RB et al. Oral triptans (serotonin 5-HT agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001; 358: 1668-75.
35. Feuer DJ, Broadley KE. Systematic review and meta-analysis of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers. Ann Oncology 1999; 10: 1035-41.
36. Flather MD, Yusuf S, Kober L et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet 2000; 355: 1575-81.
37. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 2001; 59: 260-69.
38. van Grunsven PM, van Schayck CP, Derenne JP et al. Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Thorax 1999; 54: 7-14.
39. Klijn JGM, Blarney RW, Boccardo F et al. Combined tamoxifen and lutenizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. J Clin Oncol 2001; 19: 343-53.
40. Koch A, Ziegler S, Breitschwerdt H et al. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: meta-analysis based on original patient data. Thrombosis Res 2001; 102: 295-309.
41. Latini R, Tognoni G, Maggioni AP et al. Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin. J Am Coll Cardiology 2000; 35: 1801-807.
42. Lievre M, Gueyffier F, Ekbom T et al. Efficacy of diuretics and beta-blockers in diabetic hypertensive patients. Diabeties Care 2000; 23: B65-B71.
43. Marson AG, Williamson PR, Hutton JL et al. Carbamazepine versus valproate monotherpay for epilepsy carcinoma (Cochrane review). In The Cochrane Library, Issue 4. Oxford: Update Software, 2001.
44. Mauer DK, Nolan J, Plaisance P et al. Effect of active compression-decompression resuscitation (ACD-CPR) on survival: a combined analysis using indivdual patient data. Resuscitation 1999; 41: 249-56.
45. Meta-Analysis Group in Cancer. Alpha-interferon does not increase the efficacy of 5-flourouracil in advanced colorectal cancer. Br J Cancer 2001; 84: 611-20.
46. Myeloma Trialists' Collaborative Group. Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients. Br J Haematology 2001; 113: 1020-34.
47. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy for non-small cell lung cancer carcinoma (Cochrane review). In The Cochrane Library, Issue 4. Oxford: Update Software, 2001.
48. Pignon JP, Bourhis J, Domenge C et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000; 355: 949-55.
49. Pocock SJ, McCormack V, Gueyffier F et al. A score for predicting risk of death from cardiovascular diseaese in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ 2001; 323: 75-81.
50. Prostate Cancer Trialists' Collaborative Group. Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Lancet 2000; 355: 1491-98.
51. Quan A, Kerlikowske K, Gueyffier F et al. Efficacy of treating hypertension in women. J Gen Intern Med 1999; 14: 718-29.
52. Sakamoto J, Hamada C, Kodaira S et al. Adjuvant chemotherapy with oral flouropyrimidines as main chemotherapeutic agents after curative resection for colorectal cancer: individual patient data meta-analysis of randomized trials. Jap J Clin Oncology 1999; 29: 78-86.
53. Schalm SW, Weiland O, Hansen BE et al. Inteferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Gastroenterology 1999; 117: 408-13.
54. Storosum JG, Elferinck AJA, van Zwieten BJ et al. Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study. Eur Neuropsychopharmacology 2001; 11: 173-80.
55. Taylor S, Tudur Smith C, Williamson PR et al. Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures carcinoma (Cochrane review). In The Cochrane Library, Issue 4. Oxford: Update Software, 2001.
56. Thirion P, Wolmark N, Haddad E et al. Survival impact of chemotherapy in patients with colorectal metastases confined to the liver: a re-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analyses. Ann Oncology 1999; 10: 1317-20.
57. Tudur Smith C, Marson AG, Williamson PR. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures carcinoma (Cochrane review). In The Cochrane Library, Issue 4. Oxford: Update Software, 2001.
58. Zinc Investigators' Collaborative Group. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr 2000; 72: 1516-22.
59. Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. NEJM 1988; 319: 1681-92.
60. PORT Meta-Analysis Trialists' Group. Postoperative radiotherapy in non-small-cell lung cancer. Lancet 2000; 352: 257-63.
61. Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken and interpreted. Stats Med 2002; 21: 1559-73.
62. Thompson SG, Higgins JPT. Can meta-analysis help target interventions at individuals most likely to benefit? Lancet 2005; 365: 341-46.
63. Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stats Med 1998; 17: 2815-34.
64. Higgins JPT, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stats Med 2004; 23: 1663-82.
65. Tierney JF, Clarke M, Stewart LA. Is there bias in the publication of individual patient data meta-analyses? Int J Tech Ass Health Care 2000; 16: 657-67.
66. Jeng GT, Scott JR, Burmeister LF. A comparison of meta-analytic results using literature vs individual patient data. JAMA 1995; 274: 830-36.
67. Peto R. Why do we need systematic overviews of randomised trials? Stats Med 1987; 6: 233-44.
68. Altman DG, Deeks JJ. Meta-analysis, Simpson's paradox, and the number needed to treat. BMC Medical Research Methodology 2002; 2: Epub 2002.
69. Higgins J, Thompson S, Deeks J et al. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 2002; 7: 51-61.
70. Higgins JPT, Thompson SG, Deeks JJ et al. Measuring inconsistency in a meta-analysis. BMJ 2003; 327: 557-60.
71. Thompson SG, Turner RM, Warn DE. Multilevel models for meta-analysis, and their application to absolute risk differences. Stat Meth Med Research 2001; 10: 375-92.
72. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 1990; 263: 1385-89.
73. Glioma Meta-Analysis Trialists (GMT) Group. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002; 359: 1011-18.